TFX vs UTMD
TFX: Teleflex is a medical technology company specializing in single-use devices for critical care and surgical applications, currently streamlining its portfolio to focus on core operations. UTMD: Utah Medical Products develops and manufactures specialized, cost-effective medical devices designed to improve patient safety and outcomes in labor, delivery, and neonatal intensive care.
Side-by-side fundamentals
| Metric | TFX | UTMD | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $136.71 | $70.52 | |
| Market cap as of 2026-08-03 | $6.1B | $225M | |
| P/E as of 2026-08-03 | n/a | 20.87 | |
| PEG as of 2026-08-03 | 0.74 | n/a | |
| Net margin as of 2026-08-03 | -35.9% | +28.9% | UTMD higher |
| Gross margin as of 2026-08-03 | +53.3% | +57.9% | UTMD higher |
| Operating margin as of 2026-08-03 | -7.8% | +28.8% | UTMD higher |
| ROE as of 2026-08-03 | -28.3% | +9.1% | UTMD higher |
| ROA as of 2026-08-03 | -13.9% | +8.9% | UTMD higher |
| Debt / equity as of 2026-08-03 | 0.85 | 0.00 | UTMD lower |
| Revenue growth (YoY) as of 2026-08-03 | -6.6% | -4.4% | UTMD higher |
| Revenue CAGR (3y) SEC XBRL | -10.6% | -9.7% | UTMD higher |
| Dividend yield as of 2026-08-03 | +1.0% | +1.8% | UTMD higher |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-03 | 0.69 | 0.38 | |
| 1-year return as of 2026-07-31 close | +14.4% | +26.8% | UTMD higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.